Abbott Laboratories Earnings

Abbott Laboratories’s revenue jumped 7.37% since last year same period to $11142Mn in the Q2 2025. On a quarterly growth basis, Abbott Laboratories has generated 7.57% jump in its revenue since last 3-months.

Abbott Laboratories’s net profit jumped 36.64% since last year same period to $1779Mn in the Q2 2025. On a quarterly growth basis, Abbott Laboratories has generated 34.26% jump in its net profits since last 3-months.

Abbott Laboratories’s net profit margin jumped 27.25% since last year same period to 15.97% in the Q2 2025. On a quarterly growth basis, Abbott Laboratories has generated 24.82% jump in its net profit margins since last 3-months.

Abbott Laboratories’s earning per share (EPS) estimates for the current quarter stand at 1.3 - a 3.17% jump from last quarter’s estimates.

Abbott Laboratories’s earning per share (EPS) estimates for the current year stand at 1.3.

Abbott Laboratories’s earning per share (EPS) jumped 10.53% since last year same period to 1.26 in the Q2 2025. This indicates that the Abbott Laboratories has generated 10.53% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Abbott Laboratories declared 0.59 dividend per share during the earnings announcement for Q2 2025.